Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading

详细信息    查看全文

• 作者：Kazunori Takeda (1)
  Masamichi Yokoe (2)
  Tadahiro Takada (3)
  Keisho Kataoka (4)
  Masahiro Yoshida (5)
  Toshifumi Gabata (6)
  Masahiko Hirota (7)
  Toshihiko Mayumi (8)
  Masumi Kadoya (9)
  Eigoro Yamanouchi (10)
  Takayuki Hattori (11)
  Miho Sekimoto (12)
  Hodaka Amano (3)
  Keita Wada (3)
  Yasutoshi Kimura (13)
  Seiki Kiriyama (14)
  Shinju Arata (15)
  Yoshifumi Takeyama (16)
  Morihisa Hirota (17)
  Koichi Hirata (13)
  Tooru Shimosegawa (17)
  
• 关键词：Acute pancreatitis ; Severity assessment ; Contrast ; enhanced computed tomography ; Prognostic factor
• 刊名：Journal of Hepato-Biliary-Pancreatic Sciences
• 出版年：2010
• 出版时间：January 2010
• 年：2010
• 卷：17
• 期：1
• 页码：37-44
• 全文大小：436KB
• 参考文献：1. Ogawa M, Hirota M, Hayasaka T, et al. Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas. 2002;25:325-0. CrossRef
  2. Forell MM. Die konservative Behandulung der Pankreaserkrankungen. Der Internist. 1964;5:453-.
  3. Bank S, Wise L, Gersten M. Risk factors in acute pancreatitis. Am J Gastroenterol. 1983;78:637-0.
  4. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65:337-1. CrossRef
  5. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993;128:586-0.
  6. British Society of Gastroenterology. United Kingdom guidelines for the management of acute pancreatitis. Gut. 1998; 42 S2:1S-3S.
  7. UK Working Party on Acute Pancreatitis. UK guidelines for the management of acute pancreatitis. Gut. 2005;54 Suppl III: iii1–iii9.
  8. Viedma JA, Perez MM, Agullo J, et al. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut. 1994;35:822-. CrossRef
  9. Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci. 1995;40:2341-. CrossRef
  10. Uchikov PA, Sirakova IP, Murdjeva MA, Uchikov AP. Changes in plasma levels of acute phase proteins in pancreatitis. Folia Med (Plovdiv). 2000;42:23-0.
  11. Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference. Int J Pancreatol. 1999;25:195-10.
  12. Toouli J, Brooke-Smith M, Bassi C, et al. Working party of the program committee of the Bankok World Congress of Gastroenterology 2002. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002;17(Suppl):S15-9. CrossRef
  13. Skipworth RA, Pereira SP. Acute pancreatitis. Curr Opin Crit Care. 2008;14:172-. CrossRef
  14. Rau BM, Kemppainen EA, Gumbs A, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenterstudy. Ann Surg. 2007;245:745-4. CrossRef
  15. Funnell IC, Bornman PC, Weakley SP, et al. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg. 1993;80:484-. CrossRef
  16. Martinez J, Sanchez PJ, Palazon JM, et al. Obesity: a prognostic factor of severity in acute pancreatitis. Pancreas. 1999;19:15-0. CrossRef
  17. Martinez J, Sanchez-Paya J, Palazon JM, et al. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology. 2004;4:42-. CrossRef
  18. Sempere L, Martinez J, de Madaria E, et al. Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology. 2008;8:257-4. CrossRef
  19. Hirota M, Ogawa M. Obesity in acute pancreatitis. Kan-Tan-Sui. 2001;42:53-. (in Japanese).
  20. Vesentini S, Bassi C, Talamini G, et al. Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg. 1993;80:755-. CrossRef
  21. Kemppainen E, Sainio V, Haapiainen R, et al. Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis. Br J Surg. 1996;83:924-. CrossRef
  22. Bradley EL III, Murphy F, Ferguson C. Prediction of pancreatic necrosis by dynamic pancreatography. Ann Surg. 1989;210:495-03. CrossRef
  23. Larvin M, Chalmers AG, McMahon MJ. Dynamic contrast enhanced computed tomography: a precise technique for identifying and localizing pancreatic necrosis. BMJ. 1990;300:1425-. CrossRef
  24. Lytras D, Manes K, Triantopoulou C, et al. Persistent early organ failure defining the high-risk group of patients with severe acute pancreatitis? Pancreas. 2008;36:249-4. CrossRef
  25. Carmona-Sanchez R, Uscanga L, Bezaury-Rivas P, et al. Potential harmful effect of Iodinated intravenous contrast medium on the clinical course of mild acute pancreatitis. Arch Surg. 2000;135:1280-. CrossRef
  26. Hwang TL, Chang KY, Ho YP. Contrast-enhanced dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis. Reevaluation of the effect of intravenous contrast medium on the severity of acute pancreatitis. Arch Surg. 2000;135:287-0. CrossRef
  27. Uhl W, Roggo A, Kirschstein T, et al. Influence of contrast-enhanced computed tomography on course and outcome in patients with acute pancreatitis. Pancreas. 2002;24:191-. CrossRef
  28. Matsuno S, Ogawa M, Takeda K et al. Annual report, 2001, Committee of Intractable Disease of the Pancreas, Japanese Ministry of Health, Labor and Welfare; 2001. p. 19-6 (in Japanese).
  29. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174:331-.
  30. Takeda K, Matsuno S. Management of acute necrotizing pancreatitis based on CT grading. J Abdom Emerg Med. 1998;18:961-. (in Japanese).
  31. London NJ, Leese T, Lavelle JM, et al. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study. Br J Surg. 1991;78:1452-. CrossRef
  32. Clavien PA, Hauser H, Meyer P, Rohner A. Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis. Am J Surg. 1988;155:457-6. CrossRef
  33. Rotman N, Chevret S, Pezet D, et al. Prognostic value of early computed tomographic scans in severe acute pancreatitis. J Am Coll Surg. 1994;179:538-4.
  34. Hirota M, Kimura Y, Ishiko T, et al. Visualization of the heterogenous internal structure of so-called pancreatic necrosis by magnetic resonance imaging. Pancreas. 2002;25:63-. CrossRef
  35. Ward J, Chalmers AG, Guthrie AJ, et al. T2-weighted and dynamic enhanced MRI in acute pancreatitis: comparison with contrast enhanced CT. Clin Radiol. 1997;52:109-4. CrossRef
  36. Lecesne R, Taourel P, Bret PM, et al. Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology. 1999;211:727-6.
  37. Blamey SL, Imrie CW, O’Neill J, et al. Prognostic factors in acute pancreatitis. Gut. 1984;25:1340-. CrossRef
  38. Ranson JHC, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet. 1976;143:209-9.
  39. Leese T, Shaw D. Comparison of three Glasgow multifactor prognostic scoring system in acute pancreatitis. Br J Surg. 1988;75:460-. CrossRef
  40. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg. 1990;77:1260-. CrossRef
  41. Larvin M. Assessment of severity and prognosis in acute pancreatitis. Eur J Gastroenterol Hepatol. 1997;9:122-0.
  42. Kitagawa M, Naruse T, Hayakawa T, et al. Prediction of exacerbation of acute pancreatitis. Suizou. 2005;20:17-0. (in Japanese). CrossRef
  43. Matsuno S, Takeda K, Kitagawa M et al. Annual report, 2005, Committee of Intractable Disease of the Pancreas, Japanese Ministry of Health, Labor and Welfare; 2005. p. 32- (in Japanese).
  44. Matsuno S, Takeda K, Ogawa M, et al. Re-evaluation of CT Grade in acute pancreatitis. Suizou. 2002;7:93-. (in Japanese).
  45. Takeda K, Ootsuki M, Kihara Y et al. Annual report, 2008, Committee of Intractable Disease of the Pancreas, Japanese Ministry of Health, Labor and Welfare; 2008. p. 43- (in Japanese).
  46. Yokoe M, Mayumi T, Hayashi K. Clinical evaluation of the revised staging system for acute pancreatitis in Japan. Suizou. 2009;24:140-. (in Japanese). CrossRef
  47. Bank PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101:2379-00. CrossRef
  
• 作者单位：Kazunori Takeda (1)
  Masamichi Yokoe (2)
  Tadahiro Takada (3)
  Keisho Kataoka (4)
  Masahiro Yoshida (5)
  Toshifumi Gabata (6)
  Masahiko Hirota (7)
  Toshihiko Mayumi (8)
  Masumi Kadoya (9)
  Eigoro Yamanouchi (10)
  Takayuki Hattori (11)
  Miho Sekimoto (12)
  Hodaka Amano (3)
  Keita Wada (3)
  Yasutoshi Kimura (13)
  Seiki Kiriyama (14)
  Shinju Arata (15)
  Yoshifumi Takeyama (16)
  Morihisa Hirota (17)
  Koichi Hirata (13)
  Tooru Shimosegawa (17)
  
  1. Department of Surgery, National Hospital Organization Sendai Medical Center, 2-2-8 Miyagino, Miyagino-ku, Sendai, 983-8520, Japan
  2. General Internal Medicine, Japanese Red Cross Society Nagoya Daini Hospital, Nagoya, Japan
  3. Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
  4. Otsu Municipal Hospital, Otsu, Japan
  5. Department of Hemodialysis and Surgery, Clinical Research Center, Kaken Hospital, International University of Health and Welfare, Chiba, Japan
  6. Department of Radiology, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan
  7. Department of Surgery, Kumamoto Regional Medical Center, Kumamoto, Japan
  8. Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan
  9. Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan
  10. Department of Radiology, St. Marianna University Yokohama Seibu Hospital, Yokohama, Japan
  11. Department of Radiology, National Hospital Organization Disaster Medical Center, Tokyo, Japan
  12. Department of Healthcare Economics and Quality Management, Kyoto University Graduate School of Medicine, Kyoto, Japan
  13. Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University Graduate School of Medicine, Sapporo, Japan
  14. Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan
  15. Critical Care and Emergency Center, Yokohama City University Medical Center, Yokohama, Japan
  16. Department of Surgery, Kinki University School of Medicine, Osaka, Japan
  17. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan
  

文摘

The assessment of severity at the initial medical examination plays an important role in introducing adequate early treatment and the transfer of patients to a medical facility that can cope with severe acute pancreatitis. Under these circumstances, “criteria for severity assessment-have been prepared in various countries, including Japan, and these criteria are now being evaluated. The criteria for severity assessment of acute pancreatitis in Japan were determined in 1990 (of which a partial revision was made in 1999). In 2008, an overall revision was made and the new Japanese criteria for severity assessment of acute pancreatitis were prepared. In the new criteria for severity assessment, the diagnosis of severe acute pancreatitis can be made according to 9 prognostic factors and/or the computed tomography (CT) grades based on contrast-enhanced CT. Patients with severe acute pancreatitis are expected to be transferred to a specialist medical center or to an intensive care unit to receive adequate treatment there. In Japan, severe acute pancreatitis is recognized as being a specified intractable disease on the basis of these criteria, so medical expenses associated with severe acute pancreatitis are covered by Government payment.